Magdi Nagy, PhD (@magdinagy88) 's Twitter Profile
Magdi Nagy, PhD

@magdinagy88

Postdoctoral researcher interested in #coagulation #thrombosis #stroke @CARIMMaastricht

ID: 1417935271102976004

calendar_today21-07-2021 19:51:41

50 Tweet

95 Followers

102 Following

CARIM (@carimmaastricht) 's Twitter Profile Photo

This Friday at 08.00 am, Henri Spronk will give the Cardiovascular Grand Rounds lecture: 'Assessment of hyper-coagulability and hypo-fibrinolysis in COVID patients' Henri Spronk CARIM

This Friday at 08.00 am, Henri Spronk will give the Cardiovascular Grand Rounds lecture: 'Assessment of hyper-coagulability and hypo-fibrinolysis in COVID patients'
<a href="/HSpronk/">Henri Spronk</a> <a href="/CARIMMaastricht/">CARIM</a>
CARIM (@carimmaastricht) 's Twitter Profile Photo

Join the annual CARIM symposium on 16 November! Register here👉bit.ly/3RTBRsK Several CARIM researchers will present their work. Magdi Nagy, PhD @Martijn_Hoes Jordi Heijman Leon Schurgers Reneman keynote lecture -> Peter Stenvinkel #science Marie-Jose Goumans Tilman Hackeng

Join the annual CARIM symposium on 16 November!

Register here👉bit.ly/3RTBRsK

Several CARIM researchers will present their work. <a href="/MagdiNagy88/">Magdi Nagy, PhD</a> @Martijn_Hoes <a href="/JordiHeijman/">Jordi Heijman</a> <a href="/SchurgersLeon/">Leon Schurgers</a> 
Reneman keynote lecture -&gt; <a href="/PeterStenvinkel/">Peter Stenvinkel</a> 

#science  <a href="/MJGoumans/">Marie-Jose Goumans</a> <a href="/TilmanHackeng/">Tilman Hackeng</a>
CAS-AM (@cas_am_eu) 's Twitter Profile Photo

Fantastic combined lecture by Harry Büller and Rupert Bauersachs on the medical need of FXI(a) inhibition in venous and arterial #thrombosis: do we believe in the holy grail?

Fantastic combined lecture by Harry Büller and Rupert Bauersachs on the medical need of FXI(a) inhibition in venous and arterial #thrombosis: do we believe in the holy grail?
Magdi Nagy, PhD (@magdinagy88) 's Twitter Profile Photo

Accurate description of the current times by a catch-phrase of Charles Dickens. Great introduction to the concept of planetary health by Peter Stenvinkel! CARIM

Accurate description of the current times by a catch-phrase of Charles Dickens. Great introduction to the concept of planetary health by Peter Stenvinkel! <a href="/CARIMMaastricht/">CARIM</a>
CARIM (@carimmaastricht) 's Twitter Profile Photo

We look back on a successful and inspiring #CARIMday22. See you all again next year for our 35th CARIM symposium! 🖥️bit.ly/3NWi9w4 #cardiovascular #Research

We look back on a successful and inspiring #CARIMday22. 
See you all again next year for our 35th CARIM symposium! 

🖥️bit.ly/3NWi9w4

#cardiovascular #Research
Magdi Nagy, PhD (@magdinagy88) 's Twitter Profile Photo

I am really happy to share that I received the Dekker Postdoctoral Grant from the Dutch Heart Foundation! This grant will allow me to further investigate the role of contact activation in ischemic stroke. Hartstichting CARIM Maastricht UMC+

JTH (@jthjournal) 's Twitter Profile Photo

Deep vein #thrombosis (DVT) is multifactorial disease▶️ several clinical outcomes. Aaron Iding et al find 4 distinct phenotypes were identified among DVT patients using hierarchical clustering. Maastricht UMC+ CARIM bit.ly/3Y0UKNK

Deep vein #thrombosis (DVT) is  multifactorial disease▶️  several clinical outcomes.
<a href="/Aaron_Iding/">Aaron Iding</a> et al find 4 distinct phenotypes were identified among DVT patients using hierarchical clustering. <a href="/MaastrichtUMC/">Maastricht UMC+</a> <a href="/CARIMMaastricht/">CARIM</a>
bit.ly/3Y0UKNK
Tara Lech PharmD, CACP (@anticoagpharmd) 's Twitter Profile Photo

The reversal story is far from over. VMX-C001 is actively being studied for the reversal of Factor Xa Inhibitors. Phase I data shows no safety or tolerability concerns in 42 pts on FXa-DOACs. 5min infusion, (t½) ~ 30 h Early PD data suggest good reversal by VMX-C001 #ISTH2023

The reversal story is far from over.

VMX-C001 is actively being studied for the reversal of Factor Xa Inhibitors. 

Phase I data shows no safety or tolerability concerns in 42 pts on FXa-DOACs. 5min infusion, (t½) ~ 30 h 
Early PD data suggest good reversal by VMX-C001 #ISTH2023